Revenue
97 thousand USD
2026 · USD
Exact inputs and evidence
- Revenue: 97000 USD Source
Market value is not computed: this company’s US price is per depositary share, not per ordinary share.
Annual consolidated revenue for 2026: about USD 97K, using the latest filing vintage with reviewed corrections applied. Corrected values apply reviewed corrections and remain separate from issuer reports.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-20.
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
486000 USD
280720000 shares
7.68% · 20 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
-67.3 million USD
2023-10-01 – 2024-09-30
-9.8 million USD
2023-10-01 – 2024-09-30
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-30.
Financial data available through: 2026-03-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
−USD 6.77 million
–
Current period
−USD 38.63 million
–
-38626000 − -6767000 = -31859000 USD
-6767000 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source-38626000 USD · 2025-04-01 – 2026-03-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 5.46 million
–
Current period
−USD 20.55 million
–
-20548000 − -5462000 = -15086000 USD
-5462000 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source-20548000 USD · 2025-04-01 – 2026-03-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2026 2025-04-01 – 2026-03-31 | 97000 | 23193000 Derived | -23096000 | 15530000 Derived | -38626000 | -21588000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2026 | Revenue | 97000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2026 | Year over year | No prior comparable period |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2026 | Operating margin | -23,810.3% |
|
| 2026 | Net margin | -39,820.6% |
|
| 2026 | Free cash flow margin | -22,255.7% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2026 | Operating cash flow | -20548000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2026 | Free cash flow | -21588000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2026 | Liabilities / assets | 66.6% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2026 | Current assets / current liabilities | 0.31× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2017 2016-04-01 – 2017-03-31 | USD 16.3 million Exact valueExact value: 16299000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.32 million Exact valueExact value: -1321000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2017-04-01 – 2018-03-31 | USD 123.74 million Exact valueExact value: 123741000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.07 million Exact valueExact value: -1073000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2018-04-01 – 2019-03-31 | −USD 2.64 million Exact valueExact value: -2635000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 858,000 Exact valueExact value: -858000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2019-04-01 – 2020-03-31 | −USD 5.33 million Exact valueExact value: -5333000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.71 million Exact valueExact value: -3714000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2020-04-01 – 2021-03-31 | −USD 15.83 million Exact valueExact value: -15833000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.28 million Exact valueExact value: -4284000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2021-04-01 – 2022-03-31 | −USD 16.87 million Exact valueExact value: -16870000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 6.76 million Exact valueExact value: -6764000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2022-04-01 – 2023-03-31 | −USD 104.61 million Exact valueExact value: -104611000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.07 million Exact valueExact value: -12073000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3,000 Exact valueExact value: 3000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.08 million Calculation and evidence-12073000 − 3000 USD Exact free cash flow: -12076000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2023-04-01 – 2024-03-31 | −USD 75.34 million Exact valueExact value: -75339000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14.3 million Exact valueExact value: -14297000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2024-04-01 – 2025-03-31 | −USD 6.77 million Exact valueExact value: -6767000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.46 million Exact valueExact value: -5462000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2026 2025-04-01 – 2026-03-31 | −USD 38.63 million Exact valueExact value: -38626000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 20.55 million Exact valueExact value: -20548000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.04 million Exact valueExact value: 1040000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 21.59 million Calculation and evidence-20548000 − 1040000 USD Exact free cash flow: -21588000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
341 filings · 1,258 latest values · 1,258 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001095435, 1095435, ALP, PRTG, edgar:1095435, ptgef
Also known as Alpha Compute Corp, AlphaTON Capital Corp, BONTAN CORP INC, DEALCHECK COM INC, PORTAGE BIOTECH INC., Portage Biotech Inc., Portage Biotech Inc, Portage Biotech Inc.